Module 1 for Greece: What the National Part of the Dossier Must Contain

Modules 2 to 5 are harmonised, but Module 1 is where national requirements live, and for Greece it is where many otherwise complete dossiers get stuck.

What Module 1 is

Module 1 is the regional part of the CTD. It covers administrative and prescribing information and does not contain scientific data. Its content is defined at EU level through the eCTD Module 1 specification, while the details of what a given authority expects are set nationally.

Typical contents

Depending on the procedure, a Greek Module 1 will generally include the following elements, although applicants must always check the current requirements published by the National Organisation for Medicines (EOF).

  • Cover letter and application form, with the correct procedure type and legal basis.
  • Product information: summary of product characteristics, labelling and package leaflet.
  • Specimens or mock-ups of outer and immediate packaging.
  • Information about the experts, with signed declarations and CVs.
  • Proof of fee payment and the documents on the applicant and manufacturers, such as manufacturing authorisations and GMP evidence.
  • Pharmacovigilance documents, such as the summary of the pharmacovigilance system, risk management plan and details of the qualified person.
  • Environmental risk assessment where required, and orphan or paediatric documentation if relevant.

Language and product information

Product information for the Greek market must be available in Greek. Translation quality matters because the text is reviewed linguistically and any change after approval may require a variation. Packaging text, including strength expressions and safety statements, should match the approved texts exactly.

In decentralised and mutual recognition procedures, Greece as a concerned member state expects the translation to follow the agreed English text and the QRD template wording.

Where delays come from

  • Application form errors, such as inconsistent site names or addresses.
  • Missing or outdated manufacturing and GMP documents.
  • Translations that differ from the agreed source text.
  • Mock-ups that do not reflect the final packaging or omit required elements.
  • Late handling of fees and national forms.

Plan it early

Module 1 is the section most likely to be finished last and checked least. Preparing the national part in parallel with the scientific modules, and reviewing it against the latest EOF guidance, shortens the path to approval.

Practical sequencing

Start with the administrative documents that depend on third parties, namely manufacturing authorisations, GMP evidence and signed declarations, because they take longest to arrive. Then finalise the Greek product information and mock-ups once the English text is stable. Finally, run a completeness check against the current EOF guidance and the eCTD validation criteria so that technical rejection does not delay the start of the procedure.

How PQRA helps

PQRA prepares and checks Module 1 for Greek submissions, coordinates Greek translations and mock-ups, and keeps the administrative documents aligned with the scientific dossier.

Talk to us about your dossier: Contact PQRA

CATEGORIES:

Uncategorized

Tags:

No responses yet

Leave a Reply

Your email address will not be published. Required fields are marked *